Trials / Conditions / Glaucoma, Neovascular

Glaucoma, Neovascular

12 registered clinical trials studyying Glaucoma, Neovascular — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	MicroPulse TLT - UK Study NCT05593354	Imperial College Healthcare NHS Trust	—
Enrolling By Invitation	INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predic NCT04381611	Dr. Kaweh Mansouri	—
Completed	Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caus NCT03639675	Bayer	Phase 3
Recruiting	Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT NCT03648814	Prince of Songkla University	N/A
Completed	Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma NCT03187418	Centre hospitalier de l'Université de Montréal (CHUM)	N/A
Unknown	Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study NCT02914626	LEANDRO CABRAL ZACHARIAS	Phase 3
Completed	Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients NCT02396316	Bayer	Phase 3
Completed	Baerveldt (BGI) Valve Versus Ahmed(AGV) Valve in Management of Difficult Glaucoma Cases NCT04215575	Ain Shams University	N/A
Completed	An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Oc NCT01908816	Novartis Pharmaceuticals	Phase 3
Completed	Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage NCT02647515	Ruijin Hospital	Phase 4
Completed	The Outcome of Ahmed Glaucoma Valve in Difficult Glaucoma Cases NCT04214847	Ain Shams University	N/A
Completed	Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma NCT01922154	Siriraj Hospital	Phase 4